Credit Suisse Ag Adaptive Biotechnologies Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Credit Suisse Ag holds 144,726 shares of ADPT stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

144,726

Previous 138,580 4.43%

Holding current value

$1.16 Million

Previous $679,000 31.66%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.88 - $4.8 $17,700 - $29,500	6,146 Added 4.43%	144,726 $464,000
Q4 2023 Feb 08, 2024	BUY	$3.46 - $5.33 $38,125 - $58,731	11,019 Added 8.64%	138,580 $679,000
Q3 2023 Nov 13, 2023	SELL	$5.07 - $8.44 $26,227 - $43,660	-5,173 Reduced 3.9%	127,561 $695,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $62,723 - $88,967	10,133 Added 8.27%	132,734 $890,000
Q1 2023 May 10, 2023	BUY	$7.8 - $10.11 $30,498 - $39,530	3,910 Added 3.29%	122,601 $1.08 Million
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $127,103 - $189,639	20,304 Added 20.64%	118,691 $906,000
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $51,181 - $99,763	7,874 Added 8.7%	98,387 $700,000
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $17,408 - $40,065	2,720 Added 3.1%	90,513 $732,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $103,487 - $295,531	10,226 Added 13.18%	87,793 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $239,593 - $350,775	-9,519 Reduced 10.93%	77,567 $2.18 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $79,733 - $105,894	2,656 Added 3.15%	87,086 $2.96 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $153,592 - $212,560	4,767 Added 5.98%	84,430 $3.45 Million
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $360,490 - $655,384	9,675 Added 13.82%	79,663 $3.21 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $134,804 - $196,082	2,995 Added 4.47%	69,988 $4.14 Million
Q3 2020 Nov 13, 2020	SELL	$35.79 - $48.81 $2.77 Million - $3.78 Million	-77,534 Reduced 53.65%	66,993 $3.26 Million
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $3.41 Million - $6.6 Million	136,523 Added 1705.68%	144,527 $6.99 Million
Q1 2020 May 13, 2020	BUY	$16.96 - $34.16 $135,747 - $273,416	8,004 New	8,004 $222,000
Q3 2019 Nov 12, 2019	SELL	$30.31 - $53.51 $1.85 Million - $3.26 Million	-61,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $2.46 Million - $2.95 Million	61,000 New	61,000 $2.95 Million

Others Institutions Holding ADPT

# of Institutions

205

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.14B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account